Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals

To manufacture biopharmaceuticals at clinical development stage.

By: Contract Pharma

Contract Pharma Staff

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), is partnering with Ono Pharmaceutical Co., Ltd. to manufacture new biopharmaceuticals at the clinical development stage. ONO is a R&D-oriented pharmaceutical company committed to discovering and developing innovative drugs.
 
“We are very pleased to initiate this partnership with ONO,” said Mark Womack, CBO of AGC Biologics. “We look forward to closely collaborating with ONO to manufacture innovative and important therapies.”
 
AGC Biologics’ global network spans three continents, with cGMP-compliant facilities in Seattle, WA; Boulder, CO; Copenhagen, Denmark; Heidelberg, Germany; Milan and Bresso, Italy and Chiba, Japan. Their best in class services include development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), viral vectors and genetically engineered cells.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics